Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
KI-Analyse von INVITAE CORP
Wähle eine Analyse aus und der finAgent liefert dir tiefgehende Einblicke dazu!
Neuste KI Analysen zu INVITAE CORP
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.